BioCryst Pharmaceuticals, Inc. (BCRX) Social Stream
BIOCRYST PHARMACEUTICALS INC (BCRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BCRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 11 | $30 | $12 | $19.363 | $6.09 | 217.95% |
| 2021-12-10 | 11 | $30 | $14 | $19.727 | $6.09 | 223.92% |
| 2021-12-13 | 11 | $30 | $14 | $19.636 | $6.09 | 222.43% |
| 2022-01-11 | 11 | $30 | $14 | $19.818 | $6.09 | 225.42% |
| 2022-01-26 | 10 | $30 | $14 | $20 | $6.09 | 228.41% |
| 2022-02-23 | 10 | $30 | $14 | $20.363 | $6.09 | 234.37% |
| 2022-02-24 | 10 | $30 | $14 | $21 | $6.09 | 244.83% |
| 2022-02-25 | 10 | $30 | $14 | $21.181 | $6.09 | 247.8% |
| 2022-04-11 | 10 | $30 | $14 | $20.083 | $6.09 | 229.77% |
| 2022-05-06 | 10 | $30 | $14 | $18.916 | $6.09 | 210.61% |
| 2022-05-09 | 10 | $30 | $11 | $17.916 | $6.09 | 194.19% |
| 2022-05-12 | 10 | $30 | $11 | $17.666 | $6.09 | 190.08% |
| 2022-05-13 | 10 | $30 | $11 | $17.583 | $6.09 | 188.72% |
| 2022-07-19 | 10 | $30 | $11 | $17.545 | $6.09 | 188.1% |
| 2022-08-05 | 11 | $30 | $11 | $17.454 | $6.09 | 186.6% |
| 2022-10-25 | 10 | $30 | $13 | $17.5 | $6.09 | 187.36% |
| 2022-11-02 | 10 | $30 | $13 | $17.777 | $6.09 | 191.9% |
| 2022-11-03 | 10 | $30 | $12 | $17.666 | $6.09 | 190.08% |
| 2022-12-15 | 10 | $30 | $12 | $17.333 | $6.09 | 184.61% |
| 2023-01-27 | 9 | $30 | $10 | $16.888 | $6.09 | 177.31% |
| 2023-02-08 | 10 | $30 | $10 | $16.888 | $6.09 | 177.31% |
| 2023-02-22 | 11 | $30 | $10 | $16.888 | $6.09 | 177.31% |
| 2023-02-24 | 12 | $30 | $10 | $16.181 | $6.09 | 165.7% |
| 2023-04-20 | 12 | $30 | $10 | $14.7 | $6.09 | 141.38% |
| 2023-04-24 | 12 | $30 | $10 | $15.454 | $6.09 | 153.76% |
| 2023-05-04 | 12 | $30 | $9.5 | $15.409 | $6.09 | 153.02% |
| 2023-06-06 | 12 | $30 | $9 | $15.045 | $6.09 | 147.04% |
| 2023-06-22 | 11 | $30 | $9 | $15.25 | $6.09 | 150.41% |
| 2023-07-24 | 11 | $30 | $9 | $15.25 | $6.09 | 150.41% |
| 2023-08-04 | 10 | $30 | $9 | $15.2 | $6.09 | 149.59% |
| 2023-11-03 | 11 | $30 | $6 | $14.8 | $6.09 | 143.02% |
| 2023-11-07 | 12 | $30 | $6 | $14.4 | $6.09 | 136.45% |
| 2023-11-20 | 12 | $30 | $6 | $14 | $6.09 | 129.89% |
The Trend in the Analyst Price Target
BCRX's average price target has moved up $0.22 over the prior 32 months.
Over the past 42 weeks, BCRX's average upside potential has been 107.31%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 9 | 30 | 10 | 16.888 | 10.58 | 59.62% |
| 2023-04-20 | 12 | 30 | 10 | 15.636 | 7.38 | 111.87% |
| 2023-07-24 | 11 | 30 | 9 | 15.250 | 7.36 | 107.2% |
| 2023-10-25 | 10 | 30 | 10 | 15.300 | 5.47 | 179.71% |
| 2023-11-20 | 12 | 30 | 6 | 14.000 | 5.40 | 159.26% |
BCRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 8 | 2 | 2 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
BCRX's average broker recommendation rating improved by 0.25 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BCRX as an investment opportunity.
- In terms of how BIOCRYST PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3548.71% of that group.
- In terms of how BIOCRYST PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3546.24% of that group.
- BIOCRYST PHARMACEUTICALS INC's number of analysts covering the stock is higher than 3133.34% of stocks in the mid market cap category.
- In terms of how BIOCRYST PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 996.81% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIOCRYST PHARMACEUTICALS INC are SNDL, USNA, and LNTH.
View All Top Stocks by Price Target
What is the outlook for BCRX? Use POWR Ratings for clearer insight into price direction.